Workplace Wellness That Delivers ROI
Mobile preventive screening at your office. Measurable impact on absenteeism and productivity. A wellness benefit employees actually use.
- Cardiovascular risk score (AGLA/SCORE2)
- Blood pressure + anthropometrics
- Same-day results via secure portal
- Blood draw + lipid panel
- HR dashboard
- Everything in Essential
- Blood draw: lipids, HbA1c, hs-CRP, Lp(a)
- AGLA/SCORE2 risk stratification
- Spirometry (risk-stratified)
- HR analytics dashboard
- Everything in Professional
- Echocardiography + carotid (TSA) + Doppler ultrasound
- Lifestyle coaching session
- Priority specialist referrals
- Dedicated account manager
The ROI Is Clear
Prevention pays for itself. Peer-reviewed data shows that workplace screening reduces absenteeism by 1.5 days per employee annually.
Conservative estimate: sick days avoided only. Excludes turnover, presenteeism and early-detection value.
Pilot Programme
Start small. Prove the value. Scale with confidence.
Early Detection Pays. Literally.
Reduce downstream claims, differentiate your complementary insurance, and access population health intelligence from up to 37,500 screenings per year at full network scale (phase 2).
3-Gate Partnership Framework
Legal Validation
Joint review of LAMal/VVG billing compliance. Shared legal opinion (Rechtsgutachten) on reimbursement. Regulatory sign-off from both sides.
Operational Pilot
500-1,000 policyholders in 1-2 cantons. Real claims data before and after screening. Measure actual cost savings and policyholder satisfaction.
Full Partnership
National rollout as embedded prevention benefit. Co-branded mobile units. Integrated claims workflow. Shared population health analytics platform.
Prevention Plus Add-On
A complementary insurance product (VVG) that gives policyholders access to mobile preventive screening at their workplace.
- Annual mobile screening (Professional package)
- Digital health dashboard with longitudinal tracking
- Priority referral coordination for abnormal findings
Claims Cost Reduction
Early detection dramatically reduces downstream treatment costs. The economics are compelling for both KVG and VVG books.
projected reduction in claims cost from early detection — internal estimate
vs. CHF 50,000+ for late-stage cardiovascular event treatment
for each late-stage case prevented through early screening
A Pipeline of Qualified Referrals
Mobile screening generates a steady stream of clinically validated specialist referrals. Patients arrive pre-screened with documented findings — ready for diagnostic workup, not triage.
Referral Agreements Needed
Access Pre-Screened Patient Cohorts
Our screening programme generates a unique, real-world patient database with validated biomarkers. For CROs and pharmaceutical sponsors, this means faster enrollment and higher-quality cohorts.
How It Works
- 1 Define your cohort criteria (biomarker thresholds, demographics, geography)
- 2 Patients matching criteria receive consent for trial contact, subject to KEK ethics approval
- 3 Qualified, consented leads delivered to your enrollment team with full screening data
Build on Our Platform
Ventve runs on an OpenAPI 3.0 master platform designed for interoperability. Integrate your devices, software, or services into the mobile prevention ecosystem.
Partnership Inquiry
One form for every partnership type — employers, insurers, hospitals, trial sponsors and technology partners. Tell us who you are and we will route your inquiry to the right team.
Required fields
OpenAPI 3.0
RESTful API with full spec. Patient data, screening results, referral workflows — all via secure endpoints.
Device Integration
Bring your diagnostic devices into our mobile units. We provide the integration layer.
Data & Analytics
Aggregated, anonymized population health data. Full nDSG and GDPR compliance.
Platform targets at scale
Not sure which partnership fits?
Reach out and our team will guide you to the right model.